Fulgent Genetics, Inc.
$493.16M- Market cap
- $542.88M
- Debt
- +$476.00K
- Cash
- −$50.19M
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt cap
Decision snapshot: FLGT stock price near parity vs AIR $19.73 current versus $17.90 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AIR's multiple
Implied fair value · at FLGT's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FLGT FY 2025 (ended Dec 31, 2025) · AIR FY 2026 (ended May 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
Capital structure 85% equity / 15% debt · EV / Revenue 1.77x · EV / EBITDA 16.98x
AIR carries the larger enterprise value at $5.86B against $493.16M; FLGT trades on the lower EV / Revenue multiple (1.53x vs 1.77x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FULGENT GENETICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
AAR CORP. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.00x
0.52x
Net debt / EBITDA
Leverage against operating earnings
1.15x
2.35x
Cash and equivalents
Liquid reserves on the balance sheet
$50.19M
$84.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
FLGT vs NEO
Natera, Inc.
FLGT vs NTRA
Guardant Health, Inc.
FLGT vs GH
EXACT SCIENCES CORP
FLGT vs EXAS
OPKO HEALTH, INC.
FLGT vs OPK
TransDigm Group INC
FLGT vs TDG
Spirit AeroSystems Holdings, Inc.
FLGT vs SPR
Howmet Aerospace Inc.
FLGT vs HWM
HEXCEL CORP /DE/
FLGT vs HXL
$476.00K
$893.90M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.